UBS Group’s Envision Healthcare Holdings Inc EVHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,482,765
| Closed | -$114M | – | 8674 |
|
|
2018
Q3 | $114M | Buy |
2,482,765
+110,967
| +5% | +$4.98M | 0.05% | 370 |
|
|
2018
Q2 | $104M | Buy |
2,371,798
+2,320,303
| +4,506% | +$95.3M | 0.05% | 391 |
|
|
2018
Q1 | $1.98M | Buy |
51,495
+4,498
| +10% | +$168K | ﹤0.01% | 3156 |
|
|
2017
Q4 | $1.62M | Sell |
46,997
-25,239
| -35% | -$883K | ﹤0.01% | 3369 |
|
|
2017
Q3 | $3.25M | Sell |
72,236
-129,629
| -64% | -$6.91M | ﹤0.01% | 2628 |
|
|
2017
Q2 | $12.7M | Buy |
201,865
+92,251
| +84% | +$5.32M | 0.01% | 1344 |
|
|
2017
Q1 | $6.72M | Buy |
109,614
+32,874
| +43% | +$2.2M | ﹤0.01% | 1825 |
|
|
2016
Q4 | $4.86M | Buy |
76,740
+51,268
| +201% | +$3.35M | ﹤0.01% | 2123 |
|
|
2016
Q3 | $1.7M | Sell |
25,472
-16,081
| -39% | -$1.11M | ﹤0.01% | 2993 |
|
|
2016
Q2 | $3.16M | Buy |
41,553
+8,497
| +26% | +$604K | ﹤0.01% | 2389 |
|
|
2016
Q1 | $2.02M | Sell |
33,056
-9,061
| -22% | -$595K | ﹤0.01% | 2667 |
|
|
2015
Q4 | $3.27M | Sell |
42,117
-171,584
| -80% | -$14.8M | ﹤0.01% | 2336 |
|
|
2015
Q3 | $23.5M | Buy |
213,701
+18,260
| +9% | +$2.26M | 0.02% | 793 |
|
|
2015
Q2 | $23.1M | Buy |
195,441
+73,648
| +60% | +$8.38M | 0.02% | 883 |
|
|
2015
Q1 | $14M | Buy |
121,793
+110,381
| +967% | +$12M | 0.01% | 1202 |
|
|
2014
Q4 | $1.19M | Buy |
+11,412
| New | +$1.17M | ﹤0.01% | 3434 |
|
Other funds holding EVHC
UBS Group's EVHC Position: Q4 2018 in Review
UBS Group sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 2,482,765 shares — an estimated $114M sold.
UBS Group first reported a position in EVHC in Q4 2014 and held it in 16 quarters. The position peaked at $114M in Q3 2018. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.
- UBS Group reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
- UBS Group sold 2,482,765 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $114M.
- UBS Group first reported a position in Envision Healthcare Holdings Inc in Q4 2014 and held it in 16 quarters.
- UBS Group's Envision Healthcare Holdings Inc position peaked at $114M in Q3 2018.
- 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.
Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.